KRAS Mutation is a Significant Prognostic Factor in Early Stage Lung Adenocarcinoma

BACKGROUND: The potential clinical impact of KRAS and epidermal growth factor receptor (EGFR) mutations has been investigated in lung adenocarcinomas; however, their prognostic value remains controversial. In our study, we sought to investigate the prognostic significance of driver mutations using a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Surg Pathol
Hlavní autoři: Kadota, Kyuichi, Sima, Camelia S., Arcila, Maria E., Hedvat, Cyrus, Kris, Mark G., Jones, David R., Adusumilli, Prasad S., Travis, William D.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5106330/
https://ncbi.nlm.nih.gov/pubmed/27740967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PAS.0000000000000744
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky